
P3 Health Partners Inc.
P3 Health Partners Inc. (PIII) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
piii · stock forecast · 4 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$14.00
Consensus
$9.00
-26.5% upside
Low
$4.00
Median: $9 · Last Close: $12.25
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$9.00
-26.5% upside
High Target
$14
14.3%
Low Target
$4
-67.3%
Current Price
$12.25
as of today
Based on analyst price targets, the PIII stock price prediction for the next 12 months ranges from $4 to $14. The consensus PIII price forecast of $9.00 implies -26.5% upside from the current price of $12.25.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $12.25 | ↑ 0.00% |
1-day model range: $11.96–$12.54. Peak: $12.54 (+0.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PIII · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-22 | TD Cowen | Maintains | Hold→Hold |
| 2026-05-15 | Lake Street | Maintains | Buy→Buy |
| 2026-04-02 | TD Cowen | Maintains | Hold→Hold |
| 2026-03-27 | Lake Street | Maintains | Buy→Buy |
| 2025-11-17 | Lake Street | Maintains | Buy→Buy |
| 2025-04-21 | Lake Street | Maintains | Buy→Buy |
| 2024-11-20 | TD Cowen | Maintains | Hold→Hold |
| 2024-04-01 | BTIG | Downgrade ↓ | Buy→Neutral |
| 2024-03-14 | Lake Street | Maintains | Buy→Buy |
| 2022-01-04 | William Blair | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on P3 Health Partners Inc. (PIII) stock. Of the recent 10 rating actions, 0 were upgrades and 1 were downgrades. 4 analysts currently cover PIII.
Analyst Recommendation Trends
PIII analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1.4B
↓ 1.8% YoY
Revenue Next Year
$1.5B
↑ 7.5% YoY
EPS This Year
$-0.57
EPS Next Year
$-28.01
↑ 4796.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast PIII EPS of $-0.57 for the current fiscal year, based on estimates from 1 analysts. The PIII revenue forecast is $1.4B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PIII stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PIII price target is $9.00 (-26.5% upside), with an analyst consensus of Buy.
The PIII short-term stock prediction for tomorrow is $12.25 (+0.00%).
P3 Health Partners Inc. trades on NASDAQ under the ticker PIII. The PIII stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
PIII forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month PIII price target is $9.00, with a high forecast of $14.00 and a low of $4.00. The median price target is shown in the chart above when available. This implies -26.5% potential upside from the current price of $12.25.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.